Pivotal points in the science of dementia risk reduction
- PMID: 39096928
- DOI: 10.1016/S0140-6736(24)01546-0
Pivotal points in the science of dementia risk reduction
Conflict of interest statement
MK reports honorarium from lectures from Eisai, Novo Nordisk, Nutricia, and Roche and advisory board participation from Bioartic, Lilly, Combinostics, and Nestle (personal), outside the submitted work. FM reports honorarium for advisory board participation from Memodio and Lilly (personal), outside the submitted work. KJA reports lecture honorarium from Roche (personal), outside the submitted work.
Comment on
-
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096926 No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
